News

Wolters Kluwer's CCH Tagetik Solution Leads in CPM Technology

Wolters Kluwer's CCH Tagetik Solution Leads in CPM Technology

Wolters Kluwer's Recognition in CPM Technology

Wolters Kluwer has been lauded for its exceptional solutions in the realm of corporate performance management (CPM). The company's CCH® Tagetik expert solution has been designated as a leader for another year in the Nucleus Research CPM Technology Value Matrix. This recognition reaffirms the commitment of Wolters Kluwer to provide innovative software solutions that meet the needs of today's financial professionals.

Innovative Offerings and Features

The Nucleus Research report highlights the expansive offerings of the CCH Tagetik Intelligent Platform. This platform is designed to assist financial professionals with various aspects of their roles, from financial close processes to regulatory reporting. The new features enhance data processing and analytics capabilities, ensuring that businesses can navigate the complexities of financial management with confidence.

Functionalities Recognized by Nucleus Research

CCH Tagetik's functionalities span a comprehensive portfolio that includes capabilities for financial close, consolidation, and extended planning. This integrated approach allows organizations to seamlessly connect financial and operational workflows. The emphasis on sustainability and corporate tax reporting is also crucial, as businesses increasingly prioritize ESG factors in their operations.

Feedback from Leadership

Karen Abramson, CEO of Wolters Kluwer Corporate Performance & ESG, expressed pride in this achievement. She highlighted the company's dedication to leveraging technology for digital transformation in finance. This commitment not only drives efficiency but also ensures compliance with evolving regulations, paving the way for sustainable growth in an ever-changing landscape.

Noteworthy Product Innovations

Highlights from Nucleus Research Analysis

Among the innovations acknowledged by Nucleus for the year 2025 were significant updates to the CCH Tagetik platform. These innovations include the launch of the CCH® Tagetik Intelligent Platform, which integrates artificial intelligence capabilities that enhance the accuracy and efficiency of financial data processes.

Additionally, features like AI Automapping, anomaly detection, and driver-based analysis were introduced. These capabilities not only facilitate data validation but also streamline the analysis process, thus empowering users to make informed decisions.

Introducing Ask AI

The introduction of Ask AI, a GenAI-powered tool, represents a significant advancement in user interaction with financial data. This tool provides real-time answers to user queries, making it easier for professionals to access information and generate reports independently. This level of accessibility is invaluable for organizations seeking to empower their finance teams.

Commitment to User Experience

The focus on user experience was further emphasized with the deployment of significant UI/UX updates. The customizable homepage and visual dashboards enhance user navigation, while the process hub simplifies complex workflows. These changes are designed to ensure that users can access the insights they need quickly and intuitively.

Global Impact and Corporate Performance Management

Wolters Kluwer Corporate Performance Management operates within the broader Wolters Kluwer Corporate Performance & ESG division, which is known for its leadership in technological solutions across various sectors. By offering integrated software solutions that address environmental, social, and governance (ESG) concerns, the company enables businesses to make strategic decisions that resonate with modern-day challenges.

About Wolters Kluwer

Founded with a commitment to providing critical information for professionals, Wolters Kluwer serves a diverse client base across healthcare, legal, and corporate sectors. The organization reported impressive annual revenues, a testament to its pivotal role in aiding clients in achieving effective operations.

Frequently Asked Questions

What is the CCH Tagetik expert solution?

The CCH Tagetik expert solution is a comprehensive software platform provided by Wolters Kluwer, designed for corporate performance management, including financial reporting, planning, and consolidation.

Why was Wolters Kluwer recognized as a leader?

The recognition as a leader in the Nucleus Research CPM Technology Value Matrix reflects the company's commitment to innovation and the extensive capabilities of its CCH Tagetik platform.

What innovations were highlighted in recent reports?

Innovations include advanced AI features, the introduction of Ask AI for intuitive data queries, and significant enhancements in user experience.

How does CCH Tagetik address compliance?

CCH Tagetik integrates compliance features within its functionality, ensuring that organizations can easily meet regulatory standards while driving digital transformation.

What industries does Wolters Kluwer serve?

Wolters Kluwer provides solutions across various industries, including healthcare, legal, corporate compliance, and financial sectors, enhancing decision-making and strategic planning for professionals worldwide.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Michael Burry Steps Back: Scion Asset Management Shuttered

Updated Category News Views 409

Michael Burry Withdraws Scion Asset Management Registration Michael Burry, renowned for his insightful market predictions, has recently decided to de-register his hedge fund, Scion Asset Management, LLC. This decision marks a significant transition in Burry's investment journey. Understanding the De-Registration Process According to the Securities and Exchange...

Continue Reading
Delta Air Lines Takes Legal Action Against CrowdStrike Over Disruption

Updated Category News Views 540

Delta Air Lines Challenges CrowdStrike in Court Delta Air Lines (NYSE: DAL) has taken a bold step by filing a lawsuit against CrowdStrike (NASDAQ: CRWD), arising from significant operational disruptions caused by a software update. This action is taking place in a Georgia state court, specifically the Fulton County Superior Court. Mass Flight Disruptions and Their...

Continue Reading
Innovative LungFit PH Gains Approval for Use in Australia

Updated Category News Views 178

Introduction of LungFit PH in Australia Beyond Air, Inc. (NASDAQ: XAIR) has exciting news for the medical field as it recently received market authorization for its LungFit PH system from the Australian Therapeutic Goods Administration (TGA). This development positions LungFit PH as a Class IIb medical device, designed to provide a controlled application of nitric oxide...

Continue Reading
Integral Molecular Introduces Paratope-PLUS™ for Antibody Claims

Updated Category News Views 169

Integral Molecular Unveils Paratope-PLUS™ for Enhanced Antibody Patenting This innovative technology aligns with new USPTO guidelines for writing robust antibody patent claims and supports advanced antibody engineering for unique intellectual property. Integral Molecular has launched a revolutionary service named Paratope-PLUS™. This new technology aims to improve...

Continue Reading
Nauticus Robotics Growth in Q2: A Positive Outlook Ahead

Updated Category News Views 223

Nauticus Robotics Shows Strong Growth Trajectory in Q2 Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in subsea robotics and software, has demonstrated remarkable momentum in its financial results for the second quarter. The company continues to expand its market presence and innovate its service offerings, reflecting a strong commitment to long-term,...

Continue Reading